| Product Code: ETC7777035 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Kazakhstan Cannabis Pharmaceutical Market Overview |
3.1 Kazakhstan Country Macro Economic Indicators |
3.2 Kazakhstan Cannabis Pharmaceutical Market Revenues & Volume, 2021 & 2031F |
3.3 Kazakhstan Cannabis Pharmaceutical Market - Industry Life Cycle |
3.4 Kazakhstan Cannabis Pharmaceutical Market - Porter's Five Forces |
3.5 Kazakhstan Cannabis Pharmaceutical Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Kazakhstan Cannabis Pharmaceutical Market Revenues & Volume Share, By Drugs, 2021 & 2031F |
3.7 Kazakhstan Cannabis Pharmaceutical Market Revenues & Volume Share, By Compound Type, 2021 & 2031F |
3.8 Kazakhstan Cannabis Pharmaceutical Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.9 Kazakhstan Cannabis Pharmaceutical Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.10 Kazakhstan Cannabis Pharmaceutical Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Kazakhstan Cannabis Pharmaceutical Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing acceptance of medical cannabis for various health conditions in Kazakhstan |
4.2.2 Favorable regulatory environment supporting the use of cannabis for pharmaceutical purposes |
4.2.3 Growing awareness about the potential benefits of cannabis-based pharmaceuticals in the healthcare sector in Kazakhstan |
4.3 Market Restraints |
4.3.1 Limited availability of domestically produced cannabis for pharmaceutical purposes |
4.3.2 High costs associated with importing cannabis for pharmaceutical use in Kazakhstan |
4.3.3 Lack of comprehensive research and clinical trials on the efficacy and safety of cannabis-based pharmaceuticals in Kazakhstan |
5 Kazakhstan Cannabis Pharmaceutical Market Trends |
6 Kazakhstan Cannabis Pharmaceutical Market, By Types |
6.1 Kazakhstan Cannabis Pharmaceutical Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Kazakhstan Cannabis Pharmaceutical Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 Kazakhstan Cannabis Pharmaceutical Market Revenues & Volume, By Capsules, 2021- 2031F |
6.1.4 Kazakhstan Cannabis Pharmaceutical Market Revenues & Volume, By Concentrates, 2021- 2031F |
6.1.5 Kazakhstan Cannabis Pharmaceutical Market Revenues & Volume, By Edibles, 2021- 2031F |
6.2 Kazakhstan Cannabis Pharmaceutical Market, By Drugs |
6.2.1 Overview and Analysis |
6.2.2 Kazakhstan Cannabis Pharmaceutical Market Revenues & Volume, By Epidiolex, 2021- 2031F |
6.2.3 Kazakhstan Cannabis Pharmaceutical Market Revenues & Volume, By Marinol, 2021- 2031F |
6.2.4 Kazakhstan Cannabis Pharmaceutical Market Revenues & Volume, By Cesamet, 2021- 2031F |
6.2.5 Kazakhstan Cannabis Pharmaceutical Market Revenues & Volume, By Sativex, 2021- 2031F |
6.3 Kazakhstan Cannabis Pharmaceutical Market, By Compound Type |
6.3.1 Overview and Analysis |
6.3.2 Kazakhstan Cannabis Pharmaceutical Market Revenues & Volume, By Tetrahydrocannabinol (THC), 2021- 2031F |
6.3.3 Kazakhstan Cannabis Pharmaceutical Market Revenues & Volume, By Cannabidiol (CBD), 2021- 2031F |
6.3.4 Kazakhstan Cannabis Pharmaceutical Market Revenues & Volume, By Balanced THC & CBD, 2021- 2031F |
6.4 Kazakhstan Cannabis Pharmaceutical Market, By Application |
6.4.1 Overview and Analysis |
6.4.2 Kazakhstan Cannabis Pharmaceutical Market Revenues & Volume, By Inflammation, 2021- 2031F |
6.4.3 Kazakhstan Cannabis Pharmaceutical Market Revenues & Volume, By Chronic Pain, 2021- 2031F |
6.4.4 Kazakhstan Cannabis Pharmaceutical Market Revenues & Volume, By Epilepsy, 2021- 2031F |
6.4.5 Kazakhstan Cannabis Pharmaceutical Market Revenues & Volume, By Sleep Disorders, 2021- 2031F |
6.4.6 Kazakhstan Cannabis Pharmaceutical Market Revenues & Volume, By Anorexia, 2021- 2031F |
6.4.7 Kazakhstan Cannabis Pharmaceutical Market Revenues & Volume, By Schizophrenia, 2021- 2031F |
6.5 Kazakhstan Cannabis Pharmaceutical Market, By End-Users |
6.5.1 Overview and Analysis |
6.5.2 Kazakhstan Cannabis Pharmaceutical Market Revenues & Volume, By Clinic, 2021- 2031F |
6.5.3 Kazakhstan Cannabis Pharmaceutical Market Revenues & Volume, By Hospital, 2021- 2031F |
6.6 Kazakhstan Cannabis Pharmaceutical Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 Kazakhstan Cannabis Pharmaceutical Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.6.3 Kazakhstan Cannabis Pharmaceutical Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.6.4 Kazakhstan Cannabis Pharmaceutical Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
7 Kazakhstan Cannabis Pharmaceutical Market Import-Export Trade Statistics |
7.1 Kazakhstan Cannabis Pharmaceutical Market Export to Major Countries |
7.2 Kazakhstan Cannabis Pharmaceutical Market Imports from Major Countries |
8 Kazakhstan Cannabis Pharmaceutical Market Key Performance Indicators |
8.1 Number of licensed cannabis pharmaceutical companies operating in Kazakhstan |
8.2 Investment inflow into the cannabis pharmaceutical sector in Kazakhstan |
8.3 Number of healthcare professionals trained in prescribing cannabis-based pharmaceuticals in Kazakhstan |
9 Kazakhstan Cannabis Pharmaceutical Market - Opportunity Assessment |
9.1 Kazakhstan Cannabis Pharmaceutical Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Kazakhstan Cannabis Pharmaceutical Market Opportunity Assessment, By Drugs, 2021 & 2031F |
9.3 Kazakhstan Cannabis Pharmaceutical Market Opportunity Assessment, By Compound Type, 2021 & 2031F |
9.4 Kazakhstan Cannabis Pharmaceutical Market Opportunity Assessment, By Application, 2021 & 2031F |
9.5 Kazakhstan Cannabis Pharmaceutical Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.6 Kazakhstan Cannabis Pharmaceutical Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Kazakhstan Cannabis Pharmaceutical Market - Competitive Landscape |
10.1 Kazakhstan Cannabis Pharmaceutical Market Revenue Share, By Companies, 2024 |
10.2 Kazakhstan Cannabis Pharmaceutical Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here